Medication (generic)
Omeprazole
Starting dose
20 mg once daily before breakfast
Typical titration / target
Increase to 20 mg twice daily if needed
Monitoring / notes
Reassess after 4-8 weeks and step down when controlled.
Prescribing
PPI start
Initial dosing and step-down approach for gastroesophageal reflux.
Last reviewed 2026-01-05|gi | reflux | medication
Jump to
Dosing quick reference
Medication (generic)
Pantoprazole
Starting dose
40 mg once daily before breakfast
Typical titration / target
Increase to 40 mg twice daily if needed
Monitoring / notes
Review for alarm symptoms or inadequate response.
| Medication (generic) | Starting dose | Typical titration / target | Monitoring / notes |
|---|---|---|---|
| Omeprazole | 20 mg once daily before breakfast | Increase to 20 mg twice daily if needed | Reassess after 4-8 weeks and step down when controlled. |
| Pantoprazole | 40 mg once daily before breakfast | Increase to 40 mg twice daily if needed | Review for alarm symptoms or inadequate response. |
Contraindications
- Avoid in known proton pump inhibitor hypersensitivity.
- Investigate alarm features before prolonged empiric therapy.
- Avoid indefinite continuation without a clear ongoing indication.
Renal and hepatic considerations
- In significant hepatic impairment, consider conservative dosing and closer review.
- Monitor for renal adverse-effect signals when treatment becomes prolonged.
- Reconcile drug-interaction risks before dose escalation.
Pregnancy and lactation cautions
- Confirm medication need and select pregnancy/lactation-compatible strategy.
- Use the lowest effective dose for the shortest necessary interval.
- Reassess ongoing need as clinical status changes.
Monitoring checkpoints
- Reassess response after 4-8 weeks and step down when controlled.
- Combine with lifestyle changes (weight loss, avoid late meals).
- Consider H. pylori testing if dyspepsia is prominent.
Stop or escalate criteria
- Step down or stop when symptom control is stable and no long-term indication remains.
- Escalate for dysphagia, bleeding, weight loss, progressive anemia, or persistent vomiting.
- Escalate if symptoms persist despite optimized adherence and timing.